CT-Diagnosed Sarcopenia and Cardiovascular Biomarkers in Patients Undergoing Transcatheter Aortic Valve Replacement: Is It Possible to Predict Muscle Loss Based on Laboratory Tests?-A Multicentric Retrospective Analysis.
Stefan HechtElke BoxhammerReinhard KaufmannBernhard ScharingerChristian ReiterJürgen KammlerJörg KellermairMatthias HammererHermann BlessbergerClemens SteinwenderUta C HoppeKlaus HerganMichael LichtenauerPublished in: Journal of personalized medicine (2022)
Regardless of gender, patients with imaging-based muscle degradation did not demonstrate significantly different cardiovascular biomarker expression compared to those without it.
Keyphrases
- transcatheter aortic valve replacement
- skeletal muscle
- patients undergoing
- aortic valve
- aortic stenosis
- poor prognosis
- high resolution
- computed tomography
- image quality
- mental health
- contrast enhanced
- magnetic resonance imaging
- dual energy
- heart failure
- magnetic resonance
- positron emission tomography
- binding protein
- coronary artery disease
- fluorescence imaging
- left ventricular
- community dwelling